News

The combined company, now called Micromet Inc, is headquartered in Delaware in the US with Micromet AG becoming a wholly-owned subsidiary of the merged company. Under the terms

DeCode now plans to use the discovery of the variation in chromosome 8 to develop a diagnostic test to improve screening for the disease. According to the researchers,

The product, polyethylene glycol 3350 NF for oral solution, is the AB-rated generic equivalent of Braintree’s Miralax for oral solution. According to Teva, total annual sales of the

The study showed a statistically significant reduction in the number and severity of moderate and severe hot flashes for all three doses tested. The most effective Evamist dose

GlaxoSmithKline was awarded $274.75 million, MedImmune is to receive $169.46 million, Novartis won $220.51 million, DynPort was awarded $40.97 million, and Solvay Pharmaceuticals is to receive $298.59 million.

This multi-national study was successfully initiated outside the US in 2005, and will now expand to include 17 clinical trial sites in the US. The study is one

After evaluating data from analysis recently obtained results from the first four of eight phase III clinical trials and one phase II trial, the company decided that the

According to the company, cancer breakthrough pain is a common yet under treated component of chronic pain which is characterized by its fast onset. “For breakthrough pain, you

According to data referred to by Barr, the drug had annual sales of approximately $346 million for the twelve months ended March 2006. Nasacort AQ (triamcinolone acetonide) nasal